Inspire Medical Systems, Inc. (INSP) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
54/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseINSP / S&P -13.51% / 15.20% |
LoseINSP / S&P 4.35% / 15.00% |
WinINSP / S&P 162.43% / 50.40% |
| 2026-Q11/3 |
LoseINSP / S&P -44.07% / -4.33% |
LoseINSP / S&P 8.94% / 11.30% |
WinINSP / S&P 103.23% / 27.70% |
| 2025-Q43/3 |
WinINSP / S&P 24.30% / 2.65% |
WinINSP / S&P 13.60% / 9.00% |
WinINSP / S&P 183.24% / 13.40% |
| 2025-Q32/3 |
LoseINSP / S&P -42.82% / 8.12% |
WinINSP / S&P 16.81% / 4.61% |
WinINSP / S&P 34.86% / 13.45% |
| 2025-Q22/3 |
LoseINSP / S&P -18.53% / 10.94% |
WinINSP / S&P 22.05% / 4.83% |
WinINSP / S&P 765.00% / 10.63% |
| 2025-Q11/3 |
LoseINSP / S&P -14.08% / -4.27% |
WinINSP / S&P 27.11% / 4.98% |
LoseINSP / S&P -509.43% / 10.57% |
| 2024-Q41/3 |
LoseINSP / S&P -12.16% / 2.41% |
WinINSP / S&P 28.49% / 5.25% |
LoseINSP / S&P -340.28% / 6.15% |
| 2024-Q32/3 |
WinINSP / S&P 57.70% / 5.89% |
WinINSP / S&P 32.52% / 5.89% |
LoseINSP / S&P -199.09% / 6.11% |
| 2024-Q21/3 |
LoseINSP / S&P -37.69% / 4.28% |
WinINSP / S&P 34.14% / 5.38% |
LoseINSP / S&P -114.18% / 5.12% |
| 2024-Q11/3 |
LoseINSP / S&P 5.58% / 10.56% |
WinINSP / S&P 41.71% / 5.71% |
LoseINSP / S&P -65.36% / 5.59% |
| 2023-Q41/3 |
LoseINSP / S&P 2.51% / 11.69% |
WinINSP / S&P 53.19% / 6.81% |
LoseINSP / S&P -55.28% / 7.78% |
| 2023-Q31/3 |
LoseINSP / S&P -38.87% / -3.27% |
WinINSP / S&P 63.68% / 7.52% |
LoseINSP / S&P -39.56% / -5.03% |
| 2023-Q22/3 |
WinINSP / S&P 38.69% / 8.74% |
WinINSP / S&P 74.86% / 9.50% |
LoseINSP / S&P -11.88% / -8.57% |
| 2023-Q12/3 |
LoseINSP / S&P -7.07% / 7.50% |
WinINSP / S&P 77.72% / 10.77% |
WinINSP / S&P -1.29% / -15.69% |
| 2022-Q43/3 |
WinINSP / S&P 42.01% / 7.56% |
WinINSP / S&P 74.75% / 11.88% |
WinINSP / S&P 4.55% / -17.99% |
| 2022-Q33/3 |
WinINSP / S&P -2.90% / -4.88% |
WinINSP / S&P 73.31% / 13.47% |
WinINSP / S&P 5.81% / -1.41% |
| 2022-Q21/3 |
LoseINSP / S&P -28.84% / -16.10% |
WinINSP / S&P 71.76% / 13.71% |
LoseINSP / S&P -7.51% / 11.04% |
| 2022-Q12/3 |
WinINSP / S&P 11.58% / -4.60% |
WinINSP / S&P 95.28% / 15.97% |
LoseINSP / S&P -27.23% / 42.23% |
| 2021-Q41/3 |
LoseINSP / S&P -1.21% / 11.03% |
WinINSP / S&P 102.28% / 15.00% |
LoseINSP / S&P INSP unavailable / 96.40% |
| 2021-Q32/3 |
WinINSP / S&P 20.50% / 0.58% |
WinINSP / S&P 108.78% / 10.77% |
LoseINSP / S&P INSP unavailable / 69.42% |
| 2021-Q21/3 |
LoseINSP / S&P -6.63% / 8.55% |
WinINSP / S&P 115.46% / 6.58% |
LoseINSP / S&P INSP unavailable / 51.81% |
| 2021-Q12/3 |
WinINSP / S&P 10.05% / 6.17% |
WinINSP / S&P 54.21% / -1.06% |
LoseINSP / S&P INSP unavailable / 7.39% |
| 2020-Q42/3 |
WinINSP / S&P 45.75% / 12.15% |
WinINSP / S&P 40.62% / -3.72% |
LoseINSP / S&P INSP unavailable / -33.42% |
| 2020-Q32/3 |
WinINSP / S&P 48.30% / 8.93% |
WinINSP / S&P 34.27% / -2.04% |
LoseINSP / S&P INSP unavailable / -27.10% |
| 2020-Q22/3 |
WinINSP / S&P 44.36% / 20.54% |
WinINSP / S&P 27.24% / -0.46% |
LoseINSP / S&P INSP unavailable / -27.11% |
| 2020-Q12/3 |
WinINSP / S&P -18.77% / -19.60% |
WinINSP / S&P 53.43% / 3.47% |
LoseINSP / S&P INSP unavailable / -14.75% |
| 2019-Q42/3 |
WinINSP / S&P 21.62% / 9.07% |
WinINSP / S&P 62.18% / 5.36% |
LoseINSP / S&P INSP unavailable / 2.99% |
| 2019-Q31/3 |
LoseINSP / S&P 0.61% / 1.70% |
WinINSP / S&P 62.99% / 5.02% |
LoseINSP / S&P INSP unavailable / 0.21% |
| 2019-Q22/3 |
WinINSP / S&P 6.82% / 4.30% |
WinINSP / S&P 67.23% / 6.64% |
LoseINSP / S&P INSP unavailable / 8.65% |
| 2019-Q12/3 |
WinINSP / S&P 34.39% / 13.65% |
WinINSP / S&P 70.51% / 8.12% |
LoseINSP / S&P INSP unavailable / 14.29% |
| 2018-Q42/3 |
WinINSP / S&P 0.40% / -13.52% |
WinINSP / S&P 77.10% / 9.05% |
LoseINSP / S&P INSP unavailable / 18.23% |
| 2018-Q31/3 |
WinINSP / S&P 18.00% / 7.71% |
LoseINSP / S&P INSP unavailable / 10.21% |
LoseINSP / S&P INSP unavailable / 19.06% |
| 2018-Q20/3 |
LoseINSP / S&P INSP unavailable / 3.43% |
LoseINSP / S&P INSP unavailable / 9.03% |
LoseINSP / S&P INSP unavailable / 14.46% |
| 2018-Q10/3 |
LoseINSP / S&P INSP unavailable / -0.76% |
LoseINSP / S&P INSP unavailable / 7.68% |
LoseINSP / S&P INSP unavailable / 12.46% |
| 2017-Q40/3 |
LoseINSP / S&P INSP unavailable / 6.64% |
LoseINSP / S&P INSP unavailable / 7.03% |
LoseINSP / S&P INSP unavailable / 13.82% |
| 2017-Q30/3 |
LoseINSP / S&P INSP unavailable / 4.48% |
LoseINSP / S&P INSP unavailable / 5.68% |
LoseINSP / S&P INSP unavailable / 17.57% |
| 2017-Q20/3 |
LoseINSP / S&P INSP unavailable / 3.09% |
LoseINSP / S&P INSP unavailable / 4.83% |
LoseINSP / S&P INSP unavailable / 17.74% |
| 2017-Q10/3 |
LoseINSP / S&P INSP unavailable / 6.07% |
LoseINSP / S&P INSP unavailable / 3.67% |
LoseINSP / S&P INSP unavailable / 13.32% |
| 2016-Q40/3 |
LoseINSP / S&P INSP unavailable / 3.82% |
LoseINSP / S&P INSP unavailable / 2.09% |
LoseINSP / S&P INSP unavailable / 7.05% |
| 2016-Q30/3 |
LoseINSP / S&P INSP unavailable / 3.85% |
LoseINSP / S&P INSP unavailable / 0.20% |
LoseINSP / S&P INSP unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | INSP total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -35.08% | 20.78% |
| Annualized return | -35.08% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | INSP total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -72.88% | 83.14% |
| Annualized return | -22.97% | 12.86% |
10Y · 2018-05-03 to 2026-08-27
| Metric | INSP total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 143.47% | 319.30% |
| Annualized return | 9.31% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |